PNC Financial Services Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$600 Sell
20
-2
-9% -$57 ﹤0.01% 4949
2026
Q1
$660 Hold
22
﹤0.01% 4843
2025
Q4
$719 Sell
22
-4
-15% -$129 ﹤0.01% 4764
2025
Q3
$901 Sell
26
-3
-10% -$96 ﹤0.01% 4692
2025
Q2
$812 Sell
29
-71
-71% -$1.9K ﹤0.01% 4595
2025
Q1
$2.51K Sell
100
-9
-8% -$227 ﹤0.01% 4284
2024
Q4
$3K Buy
109
+35
+47% +$976 ﹤0.01% 4184
2024
Q3
$2.13K Buy
74
+22
+42% +$599 ﹤0.01% 4279
2024
Q2
$1.29K Sell
52
-11
-17% -$312 ﹤0.01% 4375
2024
Q1
$2.03K Buy
+63
New +$2.34K ﹤0.01% 4194
2021
Q3
Sell
-167
Closed -$11K 4337
2021
Q2
$11K Sell
167
-175
-51% -$13.3K ﹤0.01% 3671
2021
Q1
$28K Buy
342
+309
+936% +$28.5K ﹤0.01% 3266
2020
Q4
$4K Sell
33
-105
-76% -$12.8K ﹤0.01% 3750
2020
Q3
$20K Sell
138
-63
-31% -$10.5K ﹤0.01% 3232
2020
Q2
$39K Buy
201
+146
+265% +$30.2K ﹤0.01% 2883
2020
Q1
$10K Buy
+55
New +$11.8K ﹤0.01% 3399
2019
Q3
Sell
-57
Closed -$7K 4039
2019
Q2
$7K Buy
+57
New +$6.76K ﹤0.01% 3663
2018
Q3
Sell
-50
Closed -$5K 4164
2018
Q2
$5K Buy
+50
New +$4.85K ﹤0.01% 3832
2018
Q1
Sell
-60
Closed -$6K 4209
2017
Q4
$6K Buy
+60
New +$5.68K ﹤0.01% 3817

Other funds holding LKFT

PNC Financial Services Group's LKFT Position: Q2 2026 in Review

PNC Financial Services Group reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 9.1% in Q2 2026, selling an estimated $57 and leaving 20 shares worth $600. The position accounts for ﹤0.01% of the portfolio, ranked #4949.

PNC Financial Services Group first reported a position in LKFT in Q4 2017 and has held it in 19 quarters since. The position peaked at $39K in Q2 2020. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • PNC Financial Services Group held 20 shares of Lakefront Biotherapeutics American Depositary Shares worth $600 as of Q2 2026.
  • PNC Financial Services Group sold 2 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $57.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4949 holding.
  • PNC Financial Services Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2017 and has held it in 19 quarters since.
  • PNC Financial Services Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $39K in Q2 2020.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.